Is Tectonic Therapeutic, Inc. (TECX) overvalued? · $567.2M cap
Tectonic Therapeutic, Inc. (TECX) is a biotechnology company listed on NASDAQ.
This page asks whether Tectonic Therapeutic, Inc. (TECX) looks expensive on cached numbers — not a short thesis.
No cached income statement for TECX, so there is no earnings base to call rich or cheap.
TECX currently screens at market cap $567.2M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next TECX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the TECX stock page for the full model, not this heading.
Not investment advice.